86R24163 EAS-F
 
  By: Paddie H.B. No. 2050
 
  Substitute the following for H.B. No. 2050:
 
  By:  Klick C.S.H.B. No. 2050
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to consent requirements for the prescription of certain
  psychoactive medications to residents of nursing facilities and
  related institutions.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 242.505, Health and Safety Code, is
  amended by amending Subsection (c) and adding Subsection (c-1) to
  read as follows:
         (c)  Subject to Subsection (c-1), consent [Consent] to the
  prescription of psychoactive medication given by a resident or by a
  person authorized by law to consent on behalf of the resident is
  valid only if:
               (1)  the consent is given voluntarily and without
  coercive or undue influence;
               (2)  the person prescribing the medication or that
  person's designee provided the following information, in a standard
  format approved by the department, to the resident and, if
  applicable, to the person authorized by law to consent on behalf of
  the resident:
                     (A)  the specific condition to be treated;
                     (B)  the beneficial effects on that condition
  expected from the medication;
                     (C)  the probable clinically significant side
  effects and risks associated with the medication; and
                     (D)  the proposed course of the medication;
               (3)  the resident and, if appropriate, the person
  authorized by law to consent on behalf of the resident are informed
  in writing that consent may be revoked; and
               (4)  the consent is evidenced in the resident's
  clinical record by:
                     (A)  a signed form prescribed by the facility or
  by a statement of the person prescribing the medication or that
  person's designee that documents that consent was given by the
  appropriate person and the circumstances under which the consent
  was obtained; and
                     (B)  the original or a copy of the written consent
  required by Subsection (c-1), if applicable.
         (c-1)  In addition to the requirements of Subsection (c),
  consent to the prescription of an antipsychotic or neuroleptic
  medication is valid only if the consent to the prescription of that
  medication is given in writing, on a form prescribed by the
  department, by a resident or by a person authorized by law to
  consent on behalf of the resident.
         SECTION 2.  This Act takes effect September 1, 2019.